Clinical Supply Regulation Resources
-
Investigational Medicinal Products: Labeling Changes And Their Implications
12/16/2022
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
Creating Accurate, Efficient, And Effective CDMO Project Proposals
8/15/2023
To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.
-
How Specialized CDMOs Help Advance Programs From Concept To Clinic
6/15/2026
Integrated drug development streamlines manufacturing, analytics, and supply to cut risk and speed timelines. Inhalation advances and flexible partnerships help therapies reach commercialization faster.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
5/15/2024
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
3/29/2021
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Clinical Supply Flexibility Where Biotech Programs Need It Most
8/10/2026
Flexible clinical development requires scalable infrastructure, strong project management, and global logistics to ensure supply continuity and regulatory compliance.
-
Managing Clinical Trial Supply Challenges In Complex Studies
Complex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
QP Certification Of Investigational Medicinal Products In The EU And UK
10/8/2026
Personal legal responsibility, post-Brexit certification rules, and a three-part documentation review shape how investigational batches reach patients in the EU and UK, and how sponsors work with their certifying QP.
-
AI-Driven Signal Management: The Future Of Drug Safety
12/19/2025
By combining autonomy with robust governance, agentic AI enables pharmacovigilance teams to move from reactive to proactive safety management, anticipating risks before they materialize.
-
A Smart Solution To Clinical Supply Management
10/28/2022
Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.